Thirteen-month registration of patients with gastroenteropancreatic endocrine tumours in France

Neuroendocrinology
Catherine Lombard-BohasFFCD-ANGH-GERCOR

Abstract

The prevalence, clinical profiles and management of gastroenteropancreatic endocrine tumours (GEP) in France are not known. From August 1, 2001 to September 1, 2002, standardized records on patients with GEP were prospectively completed in 87 participating centres. The total group amounted to 668 patients (median age: 56 years, range: 12-89). WHO performance status was 0/1 for 80.2% of patients. The primary sites were the small bowel and colon (288), pancreas (211), unknown (77), stomach (33), non-digestive primary sites (24), appendix (20), rectum-anus (12), and oesophagus or cardia (3). GEP were functional in 260 patients (39%). Most pancreatic tumours were non-functional (72%). Metastatic disease was observed in 73.4% of cases. Most tumours (85.8%) were well or moderately differentiated. Somatostatin receptor scintigraphy was performed in only 55% of patients. The following treatment modalities were employed: resection of primary tumour: 66%; systemic chemotherapy: 41%; somatostatin analogues: 44 and 26% for GEP of small intestine and pancreas, respectively; interferon: 12%, and intra-arterial hepatic (chemo)embolization in 23 and 15% of GEP arising from the midgut and pancreas, respectively. Despite their low prevalence, we...Continue Reading

Citations

Dec 11, 2013·Endocrine-related Cancer·M FraenkelUNKNOWN Knowledge NETwork
Oct 11, 2011·World Journal of Surgery·Olov NorlénGöran Åkerström
Jul 9, 2011·Journal of Korean Medical Science·Hee Kyoung JeongYoon Ho Ko
Feb 9, 2016·Diagnostics·Emma Elizabeth IlettUlrich Knigge
Aug 31, 2019·International Journal of Endocrinology·A P SantosUNKNOWN On behalf of the NETs Study Group of the Portuguese Society of Endocrinology, Diabetes and Metabolism
Jun 19, 2020·Journal of Clinical Medicine·Lola-Jade PalmieriRomain Coriat
Jan 23, 2013·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·F MiloneA Faggiano
Feb 17, 2017·Annals of Surgical Oncology·Ariana MadaniValery E P P Lemmens
May 4, 2018·Oncotarget·Aman ChauhanLowell B Anthony
May 25, 2021·Frontiers in Endocrinology·Benjamin ChevalierMarie Christine Vantyghem
Jul 24, 2021·Clinical Neurology and Neurosurgery·Ao LengJianru Xiao
May 20, 2015·Annals of Internal Medicine·Louis de MestierGuillaume Cadiot

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.